First reported 15 hours ago -
Updated 11 hours ago -
Bayer HealthCare, an unit of German conglomerate Bayer AG (BYR.L,BAYRY.PK,BAYZF.PK), reported results from the X-VeRT study showing that once-daily Xarelto
is an effective and well-tolerated alternative to dose-adjusted vitamin K antagonists or VKAs, ...
[Published RTTNews.com - 15 hours ago]